Lavipharm (Greece) Today
| LAVI Stock | EUR 0.72 0.01 1.41% |
Performance0 of 100
| Odds Of DistressOver 72
|
Lavipharm is selling for under 0.72 as of the 29th of November 2024; that is 1.41% up since the beginning of the trading day. The stock's last reported lowest price was 0.71. Lavipharm has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Lavipharm SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece. LAVIPHARM operates under Drug Manufacturers - Major classification in Greece and is traded on Athens Stock Exchange.. The company has 18.29 M outstanding shares. More on Lavipharm SA
Moving against Lavipharm Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lavipharm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lavipharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lavipharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Lavipharm SA (LAVI) is traded on Athens Exchange in Greece and employs 5 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lavipharm's market, we take the total number of its shares issued and multiply it by Lavipharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lavipharm SA operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 18.29 M outstanding shares.
Lavipharm SA has accumulated about 1.85 M in cash with 3.82 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Lavipharm Probability Of Bankruptcy
Ownership AllocationLavipharm SA maintains a total of 18.29 Million outstanding shares. Lavipharm SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.47 % of Lavipharm SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lavipharm Ownership Details
Lavipharm SA Risk Profiles
Although Lavipharm's alpha and beta are two of the key measurements used to evaluate Lavipharm's performance over the market, the standard measures of volatility play an important role as well.
Lavipharm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lavipharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Lavipharm Corporate Management
Elected by the shareholders, the Lavipharm's board of directors comprises two types of representatives: Lavipharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lavipharm. The board's role is to monitor Lavipharm's management team and ensure that shareholders' interests are well served. Lavipharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lavipharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katerina Fragioudakis | Head Chairman | Profile | |
| Vassilis Baloumis | Group CFO | Profile | |
| Panagiotis Giannouleas | COO Mang | Profile | |
| Spyridon Fotinos | Chief Officer | Profile | |
| Liana Dimitrakopoulou | Investor Officer | Profile | |
| Lucia Tweezers | VP Board | Profile | |
| Panagiotis Pavlou | Group Director | Profile |
Additional Tools for Lavipharm Stock Analysis
When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.